
Medical iSight is developing XRAI, an Extended Reality (XR) surgical cognition platform designed for minimally invasive procedures. Their software provides surgeons with crystal clear 3D anatomy visualization, tool tracking with sub-millimeter accuracy, and real-time image-based guidance. The platform aims to improve surgical outcomes by reducing adverse events, increasing OR throughput by at least 30%, and lowering cognitive load for surgeons. Initially focused on stroke procedures like Mechanical Thrombectomy, XRAI leverages AI for segmentation, soft tissue deformation, and registration algorithms, creating a proprietary IP through curated datasets. They have established collaborations with leading institutions such as NYU Langone Health and Imperial College Healthcare NHS Trust, and their technology has been featured by NVIDIA.

Medical iSight is developing XRAI, an Extended Reality (XR) surgical cognition platform designed for minimally invasive procedures. Their software provides surgeons with crystal clear 3D anatomy visualization, tool tracking with sub-millimeter accuracy, and real-time image-based guidance. The platform aims to improve surgical outcomes by reducing adverse events, increasing OR throughput by at least 30%, and lowering cognitive load for surgeons. Initially focused on stroke procedures like Mechanical Thrombectomy, XRAI leverages AI for segmentation, soft tissue deformation, and registration algorithms, creating a proprietary IP through curated datasets. They have established collaborations with leading institutions such as NYU Langone Health and Imperial College Healthcare NHS Trust, and their technology has been featured by NVIDIA.
Product: XRAI — XR + AI surgical cognition platform for 3D visualisation and intra-operative guidance
Clinical focus: Minimally invasive vascular procedures, initially mechanical thrombectomy (stroke)
Offices: New York (US) and London (UK)
Team size: ~15 employees
Funding signal: Seed round recorded (Jan 2022); company reports SAFE/Series A1 close of $2.5M (2021)
Intra-operative visualization and navigation for minimally invasive vascular/neurovascular surgery (stroke interventions).
2019
Medtech / Surgical software
Crunchbase records a Seed round announced Jan 1, 2022; amount not specified in available evidence.
2500000
Company milestones page reports SAFE and Series A1 closes raising $2.5M in 2021.
“NYU Langone Health holds an equity interest as part of a neuroradiology collaboration”